Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Klupp

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Transplantation Proceedings|May 17, 2000
Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine AM Glanemann, J Klupp, J M Langrehr, et al.
Transplantation|October 2, 2001
Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeysB Hausen, J Klupp, U Christians, et al.
Transplantation Proceedings|March 20, 1999
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantationJ Klupp, M Glanemann, W O Bechstein, et al.
Transplantation Proceedings|March 27, 2001
Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantationM Glanemann, J Klupp, J M Langrehr, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Mycophenolate mofetil added to immunosuppression after liver transplantation--first resultsJ Klupp, W O Bechstein, K P Platz, et al.
Transplantation Proceedings|June 24, 1998
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantationJ M Langrehr, A Schneller, O Guckelberger, et al.
Transplantation Proceedings|August 15, 2002
Immunosuppressive management following small bowel transplantationAndrea Raffaella Mueller, A Pascher, K-P Platz, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Transplantation Proceedings|March 27, 2001
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantationJ M Langrehr, R Lohmann, O Guckelberger, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Transplantation Proceedings|May 17, 2000
Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine AM Glanemann, J Klupp, J M Langrehr, et al.
Transplantation|October 2, 2001
Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeysB Hausen, J Klupp, U Christians, et al.
Transplantation Proceedings|March 20, 1999
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantationJ Klupp, M Glanemann, W O Bechstein, et al.
Transplantation Proceedings|March 27, 2001
Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantationM Glanemann, J Klupp, J M Langrehr, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Mycophenolate mofetil added to immunosuppression after liver transplantation--first resultsJ Klupp, W O Bechstein, K P Platz, et al.
Transplantation Proceedings|June 24, 1998
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantationJ M Langrehr, A Schneller, O Guckelberger, et al.
Transplantation Proceedings|August 15, 2002
Immunosuppressive management following small bowel transplantationAndrea Raffaella Mueller, A Pascher, K-P Platz, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Transplantation Proceedings|March 27, 2001
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantationJ M Langrehr, R Lohmann, O Guckelberger, et al.
Pageof 6